21,940 Shares in Encompass Health Co. (NYSE:EHC) Acquired by Dynamic Technology Lab Private Ltd

Dynamic Technology Lab Private Ltd acquired a new stake in shares of Encompass Health Co. (NYSE:EHC) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 21,940 shares of the company’s stock, valued at approximately $2,026,000.

Other large investors have also bought and sold shares of the company. MassMutual Private Wealth & Trust FSB grew its stake in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after acquiring an additional 137 shares during the period. CBIZ Investment Advisory Services LLC boosted its position in Encompass Health by 38.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after purchasing an additional 127 shares during the period. Tompkins Financial Corp purchased a new position in shares of Encompass Health in the fourth quarter worth about $46,000. V Square Quantitative Management LLC raised its position in shares of Encompass Health by 43.8% in the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock valued at $54,000 after purchasing an additional 177 shares during the period. Finally, Morse Asset Management Inc purchased a new stake in shares of Encompass Health during the 3rd quarter valued at approximately $68,000. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Trading Down 3.7 %

Shares of Encompass Health stock opened at $98.14 on Friday. The company has a 50 day simple moving average of $99.25 and a two-hundred day simple moving average of $97.67. The firm has a market cap of $9.88 billion, a PE ratio of 22.00, a PEG ratio of 2.31 and a beta of 0.87. Encompass Health Co. has a 1 year low of $78.53 and a 1 year high of $104.55. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a $0.17 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.69%. Encompass Health’s payout ratio is 15.25%.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Barclays boosted their target price on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, February 7th. KeyCorp increased their price objective on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Monday, February 10th. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Royal Bank of Canada reissued an “outperform” rating and issued a $110.00 price target on shares of Encompass Health in a report on Tuesday, February 11th. Finally, StockNews.com cut shares of Encompass Health from a “buy” rating to a “hold” rating in a research note on Thursday. One analyst has rated the stock with a hold rating, nine have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Encompass Health currently has a consensus rating of “Buy” and a consensus target price of $107.67.

Insiders Place Their Bets

In other news, CAO Andrew L. Price sold 5,042 shares of the business’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares in the company, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 2.10% of the stock is owned by insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.